Technology | December 23, 2013

AliveCor Expands eHealth Service to Android Users

alivecor aliveinsights ecg wireless remote access patient monitoring systems
December 23, 2013 — AliveCor announced Android compatibility for its AliveInsights analysis service, which launched for iOS (iPhone) users of the AliveCor Heart Monitor Nov. 18, 2013.
 
AliveInsights offers review of electrocardiograms (ECGs) directly through the AliveECG app. For a fee ranging from $2 to $12, patients  or physicians can choose to receive a technical review performed by a cardiac technician or a more in-depth clinical review from a Board-Certified Cardiologist. When symptoms arise, patients can receive expert analysis of their heart rhythm 24/7.
 
“I have used the expert analysis four to five times,” said Roland Guidry, AliveCor patient user. “My use of the cardiac technician review service eliminated the need for an appointment, since my cardiologist can review the reports from afar. My cardiologist has a lot of faith in the product and the fidelity of the tracing.”
 
“I like that the AliveInsights service doesn’t require a subscription and can be used as-needed if I see something abnormal,” said Lisa Vasquez, AliveCor patient user. “The service is priced very reasonably and having access to expert analysis on-demand gives me peace of mind especially if I’m traveling.”
 
The AliveCor Heart Monitor is the only U.S. Food and Drug Administration (FDA)-cleared mobile ECG recorder that supports both iPhone and Android smartphones. It records, displays, annotates, stores and transfers single-channel electrocardiogram (ECG) rhythms wirelessly using the free AliveECG app. With secure storage in the Cloud, patients can access their data confidentially anytime, anywhere and can grant access to their physician. The Heart Monitor is available for purchase in the United States by medical professionals and patients with prescriptions.
 
For more information: www.alivecor.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Overlay Init